Objective:

To establish Argentina as a reliable partner for global ophthalmology studies through improved research facilities and collaborative networks, driven by personal dedication and inquiry.

Key Findings:

• Argentina can meet international standards for ophthalmology research, as evidenced by successful trial outcomes.
• The country's demographic diversity provides valuable data for studies on retinal diseases, enhancing the relevance of findings.
• Collaborative networks and training are essential for enhancing clinical trial capacity, as shown by the establishment of RIO Latam.

Interpretation:

The development of clinical trial infrastructure in Argentina demonstrates the potential for the country to contribute significantly to global ophthalmology research, influencing practices and standards worldwide.

Limitations:

• Access to new medications remains uneven, particularly in rural areas.
• Structural barriers in healthcare persist, affecting patient recruitment and trial participation.

Conclusion:

The groundwork laid in Argentina has attracted more studies and collaborations, positioning the country as a key player in ophthalmology research, with ongoing efforts needed to sustain and expand this momentum.